Drug Information

Drug General Information
Drug ID
D02PWZ
Former ID
DNC013013
Drug Name
N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528063]
Structure
Download
2D MOL

3D MOL
Formula
C14H13NO5
Canonical SMILES
C1=CC(=C(C=C1O)O)CNC(=O)C2=CC(=CC(=C2)O)O
InChI
1S/C14H13NO5/c16-10-2-1-8(13(19)6-10)7-15-14(20)9-3-11(17)5-12(18)4-9/h1-6,16-19H,7H2,(H,15,20)
InChIKey
OFDRVQUXDYIMFW-UHFFFAOYSA-N
PubChem Compound ID
11558153
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [528063]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 528063Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4. Epub 2006 Mar 2.N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.
Ref 528063Bioorg Med Chem Lett. 2006 May 15;16(10):2682-4. Epub 2006 Mar 2.N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.